BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 29058285)

  • 1. Notch4 inhibition suppresses invasion and vasculogenic mimicry formation of hepatocellular carcinoma cells.
    Cheng R; Cai XR; Ke K; Chen YL
    J Huazhong Univ Sci Technolog Med Sci; 2017 Oct; 37(5):719-725. PubMed ID: 29058285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Androgen receptor suppresses vasculogenic mimicry in hepatocellular carcinoma via circRNA7/miRNA7-5p/VE-cadherin/Notch4 signalling.
    Bao S; Jin S; Wang C; Tu P; Hu K; Lu J
    J Cell Mol Med; 2020 Dec; 24(23):14110-14120. PubMed ID: 33118329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regorafenib inhibits migration, invasion, and vasculogenic mimicry of hepatocellular carcinoma via targeting ID1-mediated EMT.
    Zhang N; Zhang S; Wu W; Lu W; Jiang M; Zheng N; Huang J; Wang L; Liu H; Zheng M; Wang J
    Mol Carcinog; 2021 Feb; 60(2):151-163. PubMed ID: 33428809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RhoC/ROCK2 promotes vasculogenic mimicry formation primarily through ERK/MMPs in hepatocellular carcinoma.
    Zhang JG; Zhang DD; Liu Y; Hu JN; Zhang X; Li L; Mu W; Zhu GH; Li Q; Liu GL
    Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1113-1125. PubMed ID: 30779947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ZEB2 promotes vasculogenic mimicry by TGF-β1 induced epithelial-to-mesenchymal transition in hepatocellular carcinoma.
    Yang Z; Sun B; Li Y; Zhao X; Zhao X; Gu Q; An J; Dong X; Liu F; Wang Y
    Exp Mol Pathol; 2015 Jun; 98(3):352-9. PubMed ID: 25818166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Expression and Functional Significance of Runx2 in Hepatocellular Carcinoma: Its Role in Vasculogenic Mimicry and Epithelial-Mesenchymal Transition.
    Cao Z; Sun B; Zhao X; Zhang Y; Gu Q; Liang X; Dong X; Zhao N
    Int J Mol Sci; 2017 Feb; 18(3):. PubMed ID: 28264434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ROCK is involved in vasculogenic mimicry formation in hepatocellular carcinoma cell line.
    Zhang JG; Li XY; Wang YZ; Zhang QD; Gu SY; Wu X; Zhu GH; Li Q; Liu GL
    PLoS One; 2014; 9(9):e107661. PubMed ID: 25238232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Notch1 promotes vasculogenic mimicry in hepatocellular carcinoma by inducing EMT signaling.
    Jue C; Lin C; Zhisheng Z; Yayun Q; Feng J; Min Z; Haibo W; Youyang S; Hisamitsu T; Shintaro I; Shiyu G; Yanqing L
    Oncotarget; 2017 Jan; 8(2):2501-2513. PubMed ID: 27705934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Doxycycline as an inhibitor of the epithelial-to-mesenchymal transition and vasculogenic mimicry in hepatocellular carcinoma.
    Meng J; Sun B; Zhao X; Zhang D; Zhao X; Gu Q; Dong X; Zhao N; Liu P; Liu Y
    Mol Cancer Ther; 2014 Dec; 13(12):3107-22. PubMed ID: 25277383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Norcantharidin inhibits tumor growth and vasculogenic mimicry of human gallbladder carcinomas by suppression of the PI3-K/MMPs/Ln-5γ2 signaling pathway.
    Zhang JT; Sun W; Zhang WZ; Ge CY; Liu ZY; Zhao ZM; Lu XS; Fan YZ
    BMC Cancer; 2014 Mar; 14():193. PubMed ID: 24628713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long noncoding RNA n339260 promotes vasculogenic mimicry and cancer stem cell development in hepatocellular carcinoma.
    Zhao X; Sun B; Liu T; Shao B; Sun R; Zhu D; Zhang Y; Gu Q; Dong X; Liu F; Zhao N; Zhang D; Li Y; Meng J; Gong W; Zheng Y; Zheng X
    Cancer Sci; 2018 Oct; 109(10):3197-3208. PubMed ID: 30022558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and functional significance of Twist1 in hepatocellular carcinoma: its role in vasculogenic mimicry.
    Sun T; Zhao N; Zhao XL; Gu Q; Zhang SW; Che N; Wang XH; Du J; Liu YX; Sun BC
    Hepatology; 2010 Feb; 51(2):545-56. PubMed ID: 19957372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curcumin suppresses vasculogenic mimicry capacity of hepatocellular carcinoma cells through STAT3 and PI3K/AKT inhibition.
    Chiablaem K; Lirdprapamongkol K; Keeratichamroen S; Surarit R; Svasti J
    Anticancer Res; 2014 Apr; 34(4):1857-64. PubMed ID: 24692720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIF-1α promoted vasculogenic mimicry formation in hepatocellular carcinoma through LOXL2 up-regulation in hypoxic tumor microenvironment.
    Wang M; Zhao X; Zhu D; Liu T; Liang X; Liu F; Zhang Y; Dong X; Sun B
    J Exp Clin Cancer Res; 2017 Apr; 36(1):60. PubMed ID: 28449718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COE inhibits vasculogenic mimicry in hepatocellular carcinoma via suppressing Notch1 signaling.
    Jue C; Min Z; Zhisheng Z; Lin C; Yayun Q; Xuanyi W; Feng J; Haibo W; Youyang S; Tadashi H; Shintaro I; Shiyu G; Yanqing L
    J Ethnopharmacol; 2017 Aug; 208():165-173. PubMed ID: 28694103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet lysates in Hepatocellular Carcinoma patients after radiofrequency ablation facilitate tumor proliferation, invasion and vasculogenic mimicry.
    Jia G; Kong J; Yao C; Wu S; Sun W
    Int J Med Sci; 2020; 17(14):2104-2112. PubMed ID: 32922171
    [No Abstract]   [Full Text] [Related]  

  • 17. Frizzled 2-induced epithelial-mesenchymal transition correlates with vasculogenic mimicry, stemness, and Hippo signaling in hepatocellular carcinoma.
    Ou H; Chen Z; Xiang L; Fang Y; Xu Y; Liu Q; Hu Z; Li X; Huang Y; Yang D
    Cancer Sci; 2019 Apr; 110(4):1169-1182. PubMed ID: 30677195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Promotion of hepatocellular carcinoma metastasis through matrix metalloproteinase activation by epithelial-mesenchymal transition regulator Twist1.
    Zhao XL; Sun T; Che N; Sun D; Zhao N; Dong XY; Gu Q; Yao Z; Sun BC
    J Cell Mol Med; 2011 Mar; 15(3):691-700. PubMed ID: 20219012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Slug promoted vasculogenic mimicry in hepatocellular carcinoma.
    Sun D; Sun B; Liu T; Zhao X; Che N; Gu Q; Dong X; Yao Z; Li R; Li J; Chi J; Sun R
    J Cell Mol Med; 2013 Aug; 17(8):1038-47. PubMed ID: 23815612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiRNA199a-3p suppresses tumor growth, migration, invasion and angiogenesis in hepatocellular carcinoma by targeting VEGFA, VEGFR1, VEGFR2, HGF and MMP2.
    Ghosh A; Dasgupta D; Ghosh A; Roychoudhury S; Kumar D; Gorain M; Butti R; Datta S; Agarwal S; Gupta S; Krishna Dhali G; Chowdhury A; Schmittgen TD; Kundu GC; Banerjee S
    Cell Death Dis; 2017 Mar; 8(3):e2706. PubMed ID: 28358369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.